Eli Lilly & Co.’s blockbuster obesity shot Zepbound helped people with type 1 diabetes lose more than a fifth of their body ...

The injectable weight-loss drug Zepbound appears to work better in women than in men, according to a new analysis.

The move to self-administration with a syringe and needle, just like how insulin is often taken for diabetes, means a whole ...

A recent announcement by Eli Lilly suggests that the company understands the economic conundrum some patients face. Per a ...

The weight management drug Zepbound will now be sold in lower-cost vials in addition to preloaded injector pens, according to ...

Lilly clearly has an abundance of growth drivers -- and the list includes more than Mounjaro, Zepbound, and the six drugs ...

The injectable weight-loss drug Zepbound appears to work better in women than in men, according to a new analysis of the ...

Eli Lilly's weight loss treatment Zepbound might be a blockbuster in the making, but it wasn't without its challenges. See ...

Extreme hunger is common after people stop taking GLP-1 drugs like Ozempic and Wegovy, but health experts say these simple ...

Results from 4 studies revealed that women lost more weight on average than men when taking tirzepatide — but they also ...

Millions turn to compounded versions of popular weight loss drugs amid shortages and high costs.

From the more popular options like Mounjaro or Ozempic – which is technically a diabetes medication that also helps with ...